<DOC>
	<DOC>NCT00379028</DOC>
	<brief_summary>The purpose of the study is to evaluate how the airways in COPD patients, compared to healthy volunteers, absorb steroid drugs from Symbicort Turbuhaler and Seretide Diskus. The blood concentrations of the steroids will be used as surrogate marker.</brief_summary>
	<brief_title>Airway Clearance Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>COPD patients: ≥40 years of age, Diagnosed COPD with symptoms ≥1 year, Prebronchodilatory FEV1 ≤55% of PN, Productive cough with expectoration. Healthy volunteers: ≥18 years of age, Healthy, Prebronchodilatory FEV1 &gt;80% of PN, Nonsmoker COPD patients: Current respiratory tract disorder other than COPD, Asthma before 40 years of age, Significant or unstable cardiovascular disorder, Healthy volunteers: Use of any regular medication or therapy, Pregnancy or breastfeeding,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>COPD</keyword>
</DOC>